Literature DB >> 21293510

Advancements in the analysis of esophageal pH monitoring in GERD.

Tiberiu Hershcovici1, Anita Gasiorowska, Ronnie Fass.   

Abstract

Ambulatory 24 h esophageal pH monitoring enables quantification of esophageal acid exposure and assessment of the temporal relationship between symptoms and acid reflux events. Analysis of pH monitoring is currently divided into upright and recumbent periods based on the patient's body position. However, in this Review, we demonstrate that physiologic studies have shown that sleep, and not recumbency, has a greater impact on gastroesophageal reflux during night-time. The physiologic studies are further supported by clinical trials demonstrating that gastroesophageal reflux characteristics during the recumbent-awake period are similar to those in the upright rather than the recumbent-asleep period. The introduction of the integrated pH monitoring and actigraphy data analysis program offers better separation of the recumbent-awake and recumbent-asleep periods. The physiologic studies and clinical trials, as well as the availability of a better tool to measure pH during sleep, support a paradigm shift in the analysis of pH monitoring data from body position (upright or recumbent) to state of consciousness (awake or asleep).

Entities:  

Mesh:

Year:  2011        PMID: 21293510     DOI: 10.1038/nrgastro.2010.212

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  49 in total

1.  THE FREQUENCY OF DEGLUTITION IN MAN.

Authors:  C S LEAR; J B FLANAGAN; C F MOORREES
Journal:  Arch Oral Biol       Date:  1965 Jan-Feb       Impact factor: 2.633

2.  Esophageal epithelial response to gastroesophageal reflux. A quantitative study.

Authors:  L F Johnson; T R Demeester; R C Haggitt
Journal:  Am J Dig Dis       Date:  1978-06

3.  Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Authors:  S D Martinez; I B Malagon; H S Garewal; H Cui; R Fass
Journal:  Aliment Pharmacol Ther       Date:  2003-02-15       Impact factor: 8.171

4.  Stimulation and characteristics of secondary oesophageal peristalsis in normal subjects.

Authors:  M N Schoeman; R H Holloway
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

5.  Gastroesophageal reflux and pulmonary aspiration: incidence, functional abnormality, and results of surgical therapy.

Authors:  C A Pellegrini; T R DeMeester; L F Johnson; D B Skinner
Journal:  Surgery       Date:  1979-07       Impact factor: 3.982

6.  Patterns of gastroesophageal reflux in health and disease.

Authors:  T R Demeester; L F Johnson; G J Joseph; M S Toscano; A W Hall; D B Skinner
Journal:  Ann Surg       Date:  1976-10       Impact factor: 12.969

7.  Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis.

Authors:  K Adachi; H Fujishiro; T Katsube; M Yuki; M Ono; A Kawamura; M A Rumi; M Watanabe; Y Kinoshita
Journal:  J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 4.029

8.  Correlation of oesophageal acid exposure with Barrett's oesophagus length.

Authors:  R Fass; R W Hell; H S Garewal; P Martinez; G Pulliam; C Wendel; R E Sampliner
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

9.  Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007.

Authors:  Timothy Morgenthaler; Cathy Alessi; Leah Friedman; Judith Owens; Vishesh Kapur; Brian Boehlecke; Terry Brown; Andrew Chesson; Jack Coleman; Teofilo Lee-Chiong; Jeffrey Pancer; Todd J Swick
Journal:  Sleep       Date:  2007-04       Impact factor: 5.849

10.  Upper esophageal responses to intraluminal distention in man.

Authors:  D R Enzmann; G S Harell; F F Zboralske
Journal:  Gastroenterology       Date:  1977-06       Impact factor: 22.682

View more
  1 in total

1.  Necrotizing sialometaplasia-like change of the esophageal submucosal glands is associated with Barrett's esophagus.

Authors:  David R Braxton; Dana C Nickleach; Yuan Liu; Alton B Farris
Journal:  Virchows Arch       Date:  2014-05-27       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.